top of page
The Sage Group is at JPM/BIO Partnering in San Francisco from 13-16 January, 2025! Please click here to setup a meeting!
See Latest News!
30 YEARS OF GLOBAL TRANSACTIONS FOR BIOSCIENCE COMPANIES
The Sage Group
About
Track Record
Locations
Added Value
Sage Clients
Testimonials
Services
M & A
Licensing
Sage China
Sage Japan
Sage India
Team
News
Downloads
Contact
More
Use tab to navigate through the menu items.
Sage Group News
Zumutor – Licensing Opportunity for Next Generation Tumor-Directed Immunotherapeutics Harnessing the Power of NK Cells
Zumutor Biologics is a biotechnology company based in Boston, USA, and Bangalore, India, focused on advancing innovative cancer...
D-PLEX100 from Polypid for Prevention of Surgical Site Infections - Seeking a US Licensing Partner
Our client, PolyPid Ltd. ( PolyPid - Optimized Therapeutics ; NASDAQ:PYPD) has a patented surgical site infection (SSI) prevention...
Sage Group Advises Evecxia on Licensing of EVX-101, a Novel Treatment for Depression and OCD Using Serotonin Synthesis Amplification
Evecxia deploys 5-hydroxytryptophan, 5-HTP, to achieve Serotonin Synthesis Amplification. 5-HTP amplifies brain serotonin and have shown...
bottom of page
